![]() |
市场调查报告书
商品编码
1803884
医疗事务的评价(美国)- 慢性骨髓性白血病Medical Affairs Reputations (US) - Chronic Myeloid Leukemia |
本报告是根据血液科医师和肿瘤科医师的定量调查,检视了美国支持慢性骨髓性白血病 (CML) 治疗的医疗事务团队的绩效和声誉。报告提供了医生互动频率、首选沟通管道、对当前支援的满意度以及关键未满足需求的数据。竞争洞察包括竞争基准、团队的优势和不足之处,以及医生改进医疗事务服务、满足临床和资讯需求的优先事项。
|
|
FirstView 报告是基于对 LiMATM 医生进行的定量调查而开发。 LiMATM 是全球最大的医生名录,涵盖超过 300 万名医生。每位医生均根据严格的筛选标准精心挑选,以确保收集到的见解具有相关性和可靠性,能够反映顶尖医疗专业人士的真实意见和经验。调查结果以易于理解的图表形式呈现,方便您快速掌握和分析数据。凭藉 LiMATM 广泛的覆盖范围和精准度,FirstView 报告提供无与伦比的数据驱动洞察,指导策略规划,并帮助您在快速发展的医疗保健领域保持领先地位。
FirstWord Reports 是值得信赖的行业领导者,专注于製药业,为生物製药专业人士和决策者提供深入、可操作的洞察。我们深厚的行业知识使我们能够提供相关且有价值的洞察,帮助客户掌握新兴趋势,有效应对复杂挑战。凭藉广泛的研究以及来自领先专家和关键意见领袖 (KOL) 的独立客观见解,我们的报告能够提供您所需的准确性和可靠性。独家访谈和数据,以及持续的市场监测,确保全面了解市场动态。我们的报告涵盖 40 多个活跃的疾病领域,提供包括关键意见领袖 (KOL) 洞察和定量医生调查在内的医生情报,以及行业专家对医疗事务、数位健康、销售和行销、市场准入和其他领域问题的看法,使您能够做出更明智的数据驱动决策,并在快速变化的行业中保持竞争力。
This report examines the performance and reputation of Medical Affairs teams supporting therapies for chronic myeloid leukemia (CML) in the US, based on a quantitative survey of haemato-oncologists. It provides data on physician interaction frequency, preferred engagement channels, satisfaction with current support, and key unmet needs. Insights include competitive benchmarking across brands, areas where teams are exceeding or falling short, and physician priorities for improving Medical Affairs services to better meet clinical and informational needs.
|
|
FirstView reports are developed from quantitative surveys conducted with physicians selected through LiMATM, the world's largest physician directory, containing over 3 million vetted and verified physicians. Each physician is carefully chosen based on strict screening criteria to ensure the insights gathered are both relevant and reliable, reflecting the true sentiments and experiences of leading medical professionals. The findings are presented in a series of easy-to-interpret charts, enabling you to quickly grasp and analyze the data. By leveraging the vast reach and precision of LiMATM, FirstView Reports provide unparalleled, data-driven insights to guide your strategic planning and help you stay ahead in a fast-evolving healthcare landscape.
FirstWord Reports, a trusted industry leader with an exclusive focus on the pharmaceutical sector, delivers in-depth, actionable insights for biopharma professionals and decision-makers. Our deep industry knowledge enables us to provide relevant and valuable insights that help you identify emerging trends and navigate complex challenges effectively. Backed by extensive research and independent, impartial insights from leading experts and KOLs, our reports deliver the accuracy and reliability you need. With exclusive access to interviews and data unavailable elsewhere, along with ongoing market monitoring, we give you a comprehensive view of market dynamics. Covering over 40 dynamic disease areas and providing physician intelligence, including KOL insights and quantitative physician surveys, as well as industry expert views on issues in medical affairs, digital health, sales & marketing, market access, and other areas, our reports empower you to make smarter, data-driven decisions and maintain a competitive edge in a fast-moving industry.